$3.860
+0.256 (+6.63%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
RCKT 相似圖表分析預測
Alphio's RCKT stock price prediction model matches the current Rocket Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.86 (-0.03%). The 1-week path is $3.94 (+2.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Rocket Pharmaceuticals Inc 股票嗎？
Rocket Pharmaceuticals appears to be a good buy right now due to its recent positive momentum, with a 20-day price change of +24.12% and a significant cash position of over $320 million after a recent sale, which enhances its financial stability. The RSI is at 69.022, indicating strong momentum, although it is approaching overbought territory. The main risk is the negative earnings per share of -0.15 reported in the last earnings, which may affect investor confidence.
RCKT 股價於 Friday 收在 $3.86，此前上漲 +6.63%
Rocket Pharmaceuticals Inc (RCKT) last closed at $3.86, gaining +6.63%. These facts feed the 1-day and 1-week RCKT price prediction above.
分析師一致預期
Rocket Pharmaceuticals Inc（RCKT）：買進 1、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Rocket Pharmaceuticals Inc（RCKT）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 RCKT 最接近的股票，依相似度排序。
RCKT 季節性分析
Historically the probability of a positive August return for RCKT is 22.22%. March offers the highest probability of a positive month at 34.92%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。